Skip to main content
Norris Cotton Cancer Center
In This Section

Phase 2 Study of AT13387 (onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL

Principal Investigator

Frederick Lansigan

Study Number



This phase II trial studies how well onalespib works in treating patients with anaplastic large cell lymphoma, mantle cell lymphoma, or diffuse large B-cell lymphoma that has not responded to previous treatment or that has returned after a period of improvement. Onalespib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.


Phase II


Cathleen Geiger

Available at the following location(s)

  • Lebanon

View more details at

Do you need help with some of the labels on this page?
Read our glossary of terms